Equity tips:- Lupin announced that it has received a 505 (b) (2) NDA approval for its Nikita (Pitavastatin) Tablets 1 mg, 2 mg and 4 mg from the United States Food and Drug Administration (FDA). Lupin...
Create an Account
Its Free and always will be!
Bringing the investing community closer to each other and encouraging sharing and collaboration of knowledge, thoughts and ideas.
Rank | Picker Name | Avg. Rtns |
---|---|---|
1
|
Pritam Chandra Dey |
28.64 %
|
2
|
Bharat Ahluwalia |
25.12 %
|
3
|
Swami |
23.99 %
|
4
|
Darshan Parveen kumar |
21.11 %
|
5
|
SUSHIL KUMAR PATHIYAR |
19.93 %
|
Rnk | Investor Name | Gain |
---|---|---|
1
|
20%
|
|
2
|
14.35%
|
|
3
|
8.71%
|
|
3
|
8.71%
|
|
4
|
8.2%
|
295 Investors Online.
DID YOU KNOW?
Stockadda is a Free Social Network for Indian Stock Investors. Here You Can:
Publish your own Blogs
Give and Track Stock Ideas
Compare Portfolio returns with Community
and much more!